BRAF and gastrointestinal stromal tumor: Here, it should be noted that certain subtypes such as PDGFRA exon 18 D842V-mutant GIST, SDH-deficient GIST, NF1-related GIST, and BRAF-mutated GIST are usually resistant to imatinib.